浙江医药(600216.SH)发布半年度业绩，归母净利润6.73亿元，同比增长113.52%

Core Viewpoint - Zhejiang Medicine (600216.SH) reported a slight decline in revenue for the first half of 2025, but significant growth in net profit and earnings per share [1] Financial Performance - The company achieved revenue of 4.323 billion yuan, a year-on-year decrease of 1.87% [1] - The net profit attributable to shareholders reached 673 million yuan, reflecting a year-on-year increase of 113.52% [1] - The net profit after deducting non-recurring items was 666 million yuan, up 110.10% year-on-year [1] - Basic earnings per share stood at 0.70 yuan [1]